Point-of-Care TDM and the Therapeutic Drug Monitoring Market: Results at the Bedside

Traditional TDM requires sending samples to a central laboratory, with results returning hours or days later. Point-of-care (POC) TDM devices aim to deliver results faster, enabling real-time dose adjustment. This innovation is expanding the therapeutic drug monitoring market, particularly in settings where rapid decisions matter.

POC TDM is valuable for drugs with narrow therapeutic windows and time-sensitive dosing, such as certain antibiotics and anticonvulsants. According to therapeutic drug monitoring market research, POC TDM is an emerging segment, supported by advances in biosensor technology and miniaturised analytics. Growth is driven by demand for faster turnaround and decentralised testing.

Innovation includes handheld analysers, lateral flow assays, and integrated systems that connect results to clinical decision support.

Challenges include accuracy validation, cost, and regulatory requirements.

Yet the trend is clear: POC TDM will expand access and improve timeliness, and the market is expected to benefit as technology matures.

People Also Ask

Q: What is point-of-care TDM?
A: It is therapeutic drug monitoring performed near the patient, delivering faster results to support timely dose adjustment.

Q: Where is point-of-care TDM most useful?
A: It is valuable for drugs with narrow therapeutic windows and time-sensitive dosing, such as certain antibiotics and anticonvulsants.

Tags: #PointOfCare #TDM #RapidTesting #ClinicalDecisionSupport #Biosensors #MarketTrends

Διαβάζω περισσότερα